1. |
Matter CM, Chadjichristos CE, Meier P,et al. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Circulation 2006;113:1879-87.
|
2. |
Jiang C, Yang YF, Cheng SH. Fas ligand gene therapy for vascular intimal hyperplasia. Curr Gene Ther 2004;4:33-9.
|
3. |
Kavurma MM, Khachigian LM. Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ 2003;10:36-44.
|
4. |
Luo Z, Sata M, Nguyen T,et al. Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals. Circulation 1999;99:1776-9.
|
5. |
Sata M, Walsh K. Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels. J Mol Cell Cardiol 2000;32:1395-400.
|
6. |
Belanger AJ, Scaria A, Lu H,et al. Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells:therapeutic implications of fratricidal mode of action. Cardiovasc Res 2001;51:749-61.
|
7. |
Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009;460:587-91.
|
8. |
Zhang QJ, Wang Z, Chen HZ,et al. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 2008;80:191-9.
|
9. |
Mattagajasingh I, Kim CS, Naqvi A,et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 2007;104:14855-60.
|
10 |
Stein S, Lohmann C, Sch000e4;fer N,et al. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 2010;31:2301-9.
|
11 |
Yeung F, Hoberg JE, Ramsey CS,et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004;23:2369-80.
|
12 |
Takemura A, Iijima K, Ota H,et al. Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2011;31:2054-62.
|
13 |
Li L, Zhang HN, Chen HZ,et al. SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circ Res 2011;108:1180-9.
|
14 |
Gorenne I, Kumar S, Gray K,et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis. Circulation 2013;127:386-96.
|
15 |
Zhang R, Chen HZ, Liu JJ,et al. SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem 2010;285:7097-110.
|
16 |
Tanny JC, Dowd GJ, Huang J,et al. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell 1999;99:735-45.
|
17 |
Vaziri H, Dessain SK, Ng Eaton E,et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001;107:149-59.
|
18 |
Takata T, Ishikawa F. Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochem Biophys Res Commun 2003;301:250-7.
|
19 |
Lysiak JJ, Turner SD, Turner TT. Molecular pathway of germ cell apoptosis following ischemia/reperfusion of the rat testis. Biol Reprod 2000;63:1465-72.
|
20 |
Sata M, Perlman H, Muruve DA,et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci U S A 1998;95:1213-7.
|
21 |
Weinlich R, Brunner T, Amarante-Mendes GP. Control of death receptor ligand activity by posttranslational modifications. Cell Mol Life Sci 2010;67:1631-42.
|
22 |
Mano T, Luo Z, Malendowicz SL,et al. Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery. Circ Res 1999;84:647-54.
|
23 |
Tan NY, Li JM, Stocker R,et al. Angiotensin II-inducible smooth muscle cell apoptosis involves the angiotensin II type 2 receptor, GATA-6 activation, and FasL-Fas engagement. Circ Res 2009;105:422-30.
|
24 |
Suzuki E, Evans T, Lowry J,et al. The human GATA-6 gene:structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals. Genomics 1996;38:283-90.
|
25 |
Li L, Gao P, Zhang H,et al. SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy. Acta Biochim Biophys Sin (Shanghai) 2011;43:103-9.
|